“Subsequent Radiotherapy Shows Antitumor Effects in Advanced Hepatocellular Carcinoma with Unsatisfactory Response to Immune Checkpoint Inhibitor Therapy”

https://pubmed.ncbi.nlm.nih.gov/38115944

This study found that subsequent radiotherapy in patients with advanced-stage hepatocellular carcinoma who had unsatisfactory response to immune checkpoint inhibitor therapy showed reliable antitumor effects and an acceptable safety profile, suggesting it could be an optional salvage strategy.